Wintest
6721
Showcase
3909
Beauty Kadan Holdings
3041
Cybozu
4776
KODAMA CHEMICAL INDUSTRY
4222
(FY)Sep 30, 2024 | (Q2)Mar 31, 2024 | (Q1)Dec 31, 2023 | (FY)Sep 30, 2023 | (Q4)Sep 30, 2023 | (Q3)Jun 30, 2023 | (Q2)Mar 31, 2023 | (Q1)Dec 31, 2022 | (FY)Sep 30, 2022 | (Q4)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | -31.84%2.31B | -22.21%619.35M | -25.28%623.06M | -27.93%3.39B | -34.05%916.33M | -23.05%844.26M | -29.99%796.15M | -22.84%833.84M | -4.38%4.7B | 1.88%1.39B |
Cost of revenue | -25.80%1.78B | -24.11%471.22M | -27.12%475.33M | -28.57%2.41B | -24.45%591.51M | -33.54%540.95M | -30.06%620.96M | -26.16%652.18M | -6.94%3.37B | -29.00%782.92M |
Gross profit | -46.59%526.03M | -15.45%148.12M | -18.68%147.73M | -26.30%984.95M | -46.45%324.81M | 7.10%303.31M | -29.75%175.18M | -7.98%181.66M | 2.72%1.34B | 132.29%606.52M |
Operating expense | 13.44%941.34M | -5.84%185.79M | -9.07%196.91M | -13.00%829.8M | -10.65%209.31M | -15.94%206.64M | -15.02%197.31M | -10.33%216.54M | 3.30%953.76M | -1.49%234.26M |
Operating profit | -367.68%-415.31M | -70.23%-37.67M | -40.96%-49.18M | -59.46%155.15M | -68.97%115.5M | 158.65%96.67M | -228.78%-22.13M | 20.84%-34.89M | 1.31%382.74M | 1,498.15%372.26M |
Net non-operating interest income (expenses) | 49.52%-6.1M | 47.26%-1.78M | 40.26%-1.88M | 29.62%-12.08M | 64.07%-2.13M | 3.66%-3.43M | 8.14%-3.38M | 21.25%-3.14M | -94.43%-17.16M | -105.47%-5.94M |
Non-operating interest income | 1,230.00%133K | 20.00%6K | --0 | -96.40%10K | 25.00%5K | --0 | -98.18%5K | --0 | -89.84%278K | -99.49%4K |
Non-operating interest expense | -48.46%6.23M | -47.16%1.79M | -40.26%1.88M | -30.69%12.09M | -64.01%2.14M | -3.66%3.43M | -14.39%3.38M | -21.25%3.14M | 50.83%17.44M | 61.52%5.94M |
Net investment income | -166.11%-9.14M | 1,117.67%26.81M | 58.32%-13.76M | -84.91%13.83M | -45.91%12.62M | -19.40%32.03M | -89.02%2.2M | -488.97%-33.02M | 459.38%91.61M | 601.02%23.32M |
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | -254.57%-30.03M | -718K | 82.70%-489K | 21,979.55%19.43M | 409.93%3.85M | 1,653.05%18.41M | 0 | -283.81%-2.83M | 100.62%88K | 755K |
Income from associates and other participating interests | ||||||||||
Special income (charges) | -18,300.52%-891.69M | 95.59%-3K | -10.68M | 93.83%-4.85M | 89.92%-4.74M | 99.77%-42K | 99.05%-68K | 0 | -135.19%-78.54M | -249.22%-47M |
Less:Restructuring and mergern&acquisition | --32.38M | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 100.23%520K | ---- |
Less:Other special charges | -20,353.78%-981.5M | --3K | --10.68M | -88.26%4.85M | -51.31%4.74M | -99.77%42K | ---- | ---- | 2,752.38%41.27M | --9.73M |
Less:Write off | --1.84B | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --36.75M | ---- |
Other non-operating income (expenses) | 72.33%-5.92M | 127.45%2.46M | -19.96%-7.49M | 60.98%-21.41M | 98.28%-467K | 42.91%-5.75M | -118.01%-8.95M | 53.88%-6.24M | -87.87%-54.87M | -566.86%-27.16M |
Income before tax | -1,004.99%-1.36B | 66.28%-10.9M | -4.18%-83.48M | -53.66%150.08M | -60.59%124.63M | 199.59%137.89M | -269.96%-32.31M | -39.55%-80.12M | -42.70%323.86M | 15,879.99%316.24M |
Income tax | 208.19%168.03M | -81.70%2.13M | 22.91%3.48M | -55.70%54.52M | -64.13%33.5M | -52.25%6.56M | 47.83%11.63M | -65.00%2.83M | 49.71%123.08M | 898.68%93.39M |
Net income | -1,697.21%-1.53B | 70.36%-13.02M | -4.82%-86.96M | -52.41%95.56M | -59.11%91.13M | 306.69%131.33M | -494.28%-43.94M | -26.63%-82.96M | -58.43%200.78M | 3,122.60%222.86M |
Net income continuous operations | -1,697.19%-1.53B | 70.36%-13.02M | -4.82%-86.96M | -52.41%95.56M | -59.11%91.13M | 306.70%131.33M | -494.28%-43.94M | -26.63%-82.96M | -58.43%200.78M | 3,123.02%222.86M |
Noncontrolling interests | 174.35%5.38M | -7.07%460K | -69.04%178K | 938.03%1.96M | 913.21%431K | 2,016.67%460K | 566.98%495K | 1,227.45%575K | 20.68%-234K | -76.67%-53K |
Net income attributable to the company | -1,736.42%-1.53B | 69.65%-13.49M | -4.31%-87.14M | -53.44%93.6M | -59.31%90.7M | 304.95%130.87M | -495.00%-44.44M | -27.61%-83.53M | -58.41%201.02M | 3,136.08%222.91M |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | -1,736.42%-1.53B | 69.65%-13.49M | -4.31%-87.14M | -53.44%93.6M | -59.31%90.7M | 304.95%130.87M | -495.00%-44.44M | -27.61%-83.53M | -58.41%201.02M | 3,136.08%222.91M |
Gross dividend payment | ||||||||||
Basic earnings per share | -1,741.82%-18.06 | 69.23%-0.16 | -4.04%-1.03 | -53.59%1.1 | -59.32%1.07 | 305.26%1.54 | -471.43%-0.52 | -26.92%-0.99 | -61.46%2.37 | 1,295.45%2.63 |
Diluted earnings per share | -1,741.82%-18.06 | 69.47%-0.16 | -4.04%-1.03 | -53.59%1.1 | -59.31%1.0695 | 305.26%1.54 | -494.99%-0.524 | -26.92%-0.99 | -60.89%2.37 | 1,151.43%2.6286 |
Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00%2 | 0.00%2 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |